Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EMTRICITABINE\TENOFOVIR DISOPROXIL vs ENALAPRIL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

EMTRICITABINE\TENOFOVIR DISOPROXIL vs ENALAPRIL: Safety Overview

Metric EMTRICITABINE\TENOFOVIR DISOPROXIL ENALAPRIL
Total FAERS Reports 39,362 7,730
Deaths Reported 1,254 711
Death Rate 3.2% 9.2%
Hospitalizations 4,560 3,919
Average Patient Age 46.1 yrs 63.5 yrs
% Female Patients 29.8% 49.3%
FDA Approval Date N/A Aug 10, 2021
Manufacturer N/A Bionpharma Inc.
Route N/A ORAL
Marketing Status N/A Prescription